BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 10509158)

  • 1. Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.
    Seong D; Kantarjian HM; Albitar M; Arlinghaus R; Xu J; Talpaz M; Rios MB; Guo JQ; O'Brien S; Siciliano M
    Ann Oncol; 1999 Aug; 10(8):955-9. PubMed ID: 10509158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Philadelphia negative chronic myelogenous leukemia with the chimeric BCR/ABL gene on chromosome 9 and a b3-a2 splice junction.
    Macera MJ; Smith LJ; Frankel E; Szabo P; Verma RS
    Cancer Genet Cytogenet; 1998 Mar; 101(2):143-7. PubMed ID: 9494617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of fluorescence in situ hybridization technique in diagnosis of variant Ph chromosome translocation and Ph-negative chronic myelocytic leukemia].
    Jing Y; Jiang F; Lin S; Wang FT; Fang MY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):563-6. PubMed ID: 20931538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.
    Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D
    Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
    Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
    Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
    Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
    Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
    Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
    Inokuchi K; Dan K
    J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
    Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
    Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia.
    Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Saito M; Miura AB
    Cancer Genet Cytogenet; 1996 Jul; 89(2):166-9. PubMed ID: 8697426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
    Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
    Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.
    Seong DC; Kantarjian HM; Ro JY; Talpaz M; Xu J; Robinson JR; Deisseroth AB; Champlin RE; Siciliano MJ
    Blood; 1995 Sep; 86(6):2343-9. PubMed ID: 7662980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
    Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
    Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia.
    Costa D; Espinet B; Queralt R; Carrió A; Solé F; Colomer D; Cervantes F; Hernández JA; Besses C; Campo E
    Cancer Genet Cytogenet; 2003 Mar; 141(2):114-9. PubMed ID: 12606128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.